Publication | Open Access
Sorafenib for Older Patients With Renal Cell Carcinoma: Subset Analysis From a Randomized Trial
136
Citations
19
References
2008
Year
Among patients with advanced renal cell carcinoma receiving sorafenib treatment, outcomes of older (>or=70 years) and younger (<70 years) patients were similar.
| Year | Citations | |
|---|---|---|
Page 1
Page 1